FdaApplication
ANDA 091537
Identifiers
- fda_app_no: ANDA091537
Properties
| Property | Value |
|---|---|
| applicant_name | NATCO PHARMA USA LLC |
| application_type | ANDA |
| approval_date | 2011-03-30 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RISPERIDONE | RISPERIDONE | 3MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| RISPERIDONE | RISPERIDONE | 2MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| RISPERIDONE | RISPERIDONE | 1MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| RISPERIDONE | RISPERIDONE | 0.5MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| RISPERIDONE | RISPERIDONE | 0.25MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| RISPERIDONE | RISPERIDONE | 4MG | TABLET, ORALLY DISINTEGRATING;ORAL |
6 products